JHIU
WST icon

Janus Henderson Investors US’s West Pharmaceutical WST Stock Holding History

Janus Henderson Investors US’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		$16.1M Sell
197,500
-13,700
-6% -$1.15M 0.01% 640
2016
Q4 		$17.9M Sell
211,200
-11,400
-5% -$896K 0.02% 631
2016
Q3 		$16.6M Buy
222,600
+214,900
+2,791% +$17.1M 0.01% 622
2016
Q2 		$584K Buy
+7,700
New +$560K ﹤0.01% 1060

Other funds holding WST

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Janus Henderson Investors US's WST Position: Q1 2017 in Review

Janus Henderson Investors US reduced its West Pharmaceutical (WST) stake by 6.5% in Q1 2017, selling an estimated $1.15M and leaving 197,500 shares worth $16.1M. The position accounts for 0.01% of the portfolio, ranked #640.

Janus Henderson Investors US first reported a position in WST in Q2 2016 and has held it in 4 quarters since. The position peaked at $17.9M in Q4 2016. 295 funds tracked by Wall St. Rank hold WST as of Q1 2017.

  • Janus Henderson Investors US held 197,500 shares of West Pharmaceutical worth $16.1M as of Q1 2017.
  • Janus Henderson Investors US sold 13,700 West Pharmaceutical shares in Q1 2017, an estimated $1.15M.
  • West Pharmaceutical made up 0.01% of Janus Henderson Investors US's portfolio in Q1 2017, its #640 holding.
  • Janus Henderson Investors US first reported a position in West Pharmaceutical in Q2 2016 and has held it in 4 quarters since.
  • Janus Henderson Investors US's West Pharmaceutical position peaked at $17.9M in Q4 2016.
  • 295 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2017.

Based on Janus Henderson Investors US's 13F filing for Q1 2017, filed 16 May 2017.